Understanding the true burden of COPD: The epidemiological challenges

Primary Care Respiratory Journal

Volumn 21, Issue 3, 2012, Pages 249-251

  Salvi, Sundeep S ^a   Manap, Roslina ^b   Beasley, Richard ^c  

^a Chest Research Foundation   (India)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ASTHMA; BIDI SMOKING; BIOFUEL PRODUCTION; CAUSE OF DEATH; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; EPIDEMIOLOGICAL DATA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INDIA; LOWER LIMIT OF NORMAL FORCED EXPIRATORY VOLUME FORCED VITAL CAPACITY RATIO; LOWER RESPIRATORY TRACT INFECTION; LUNG EMPHYSEMA; LUNG TUBERCULOSIS; MORTALITY; PREVALENCE; RESPIRATORY TRACT PARAMETERS; RISK FACTOR; SOCIAL STATUS; SPIROMETRY; SYSTEMATIC REVIEW (TOPIC);

HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84866359336     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00082     Document Type: Editorial

References (27)

1. Murray CL, Lopez AD. Alternative projections of mortality, disability by cause 1990-2020. Global Burden of Disease Study. Lancet 1997;349:1498-504. http://dx.doi.org/10.1016/S0140-6736(96)07492-2
2. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006;27(2):397-412. http://dx.doi.org/10.1183/09031936.06.00025805
3. The Global Burden of Disease 2008. WHO. http://www.who.int/healthinfo/global_burden_disease/projections/en/. Accessed on 8th August 2012.
4. Tan WC, Ng TP. COPD in Asia: Where East meets West. Chest 2008;133(2):517-27. http://dx.doi.org/10.1378/chest.07-1131
5. Chan-Yeung M, Ait-Khalet N, White N, Ip MS, Tan WC. The burden and impact of COPD in Asia and Africa. Int J Tuber Lung Dis 2004;8(1):2-14.
6. McKay A, Mahesh PA, Fordham JZ, Majeed A. Prevalence of COPD in India: A systematic review. Prim Care Respir J 2012;21:313-21. http://dx.doi.org/10.4104/pcrj.2012.00055
7. Chhabra SK, Rajpal S, Gupta R. Patterns of smoking in Delhi and comparison of chronic respiratory morbisity among beedi and cigarette smokers. Indian J Chest Dis Allied Sci 2001;43:19-26.
8. Salvi S, Agrawal A. India needs a national COPD prevention and control program. J Asso Phys India (Suppl) 2012;60:5-7.
9. Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest 2010;138(1):3-6.
10. Petty TL. The history of COPD. Int J Chronic Obst Pulm Dis 2006;1(1):3-14. http://dx.doi.org/10.2147/copd.2006.1.1.3
11. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to define the disorders of the syndrome of COPD. Lancet 2009;374(9691):670-2. http://dx.doi.org/10.1016/S0140-6736(09)61541-5
12. NHLBI/WHO WORKSHOP REPORT Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda, MD, National Institutes of Health-National Heart, Lung and Blood Institute: April 2001.
13. Buist AS, Vollmer WM, Sullivan SD, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005;2(2):277-83. http://dx.doi.org/10.1081/COPD-57610
14. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004; 23(6):932-46. http://dx.doi.org/10.1183/09031936.04.00014304
15. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2008 update-highlights for primary care. Can Respir J 2008;15 Suppl A:1A-8A.
16. O'Reilly J, Jones MM, Parnham J, Lovibond K, Rudolf M; Guideline Development Group. Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance. BMJ 2010;340:c3134. http://dx.doi.org/10.1136/bmj.c3134
17. Hansen JE, Sun XG, Wasserman K. Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not less than 70%. Chest 2007;131(2):349-55. http://dx.doi.org/10.1378/chest.06-1349
18. Roberts SD, Farber MO, Knox KS, et al. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006;130(1):200-06. http://dx.doi.org/10.1378/chest.130.1.200
19. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-68. http://dx.doi.org/10.1183/09031936.05.00035205
20. Postma DS, Brusselle G, Bush A, Holloway JW. I have taken my umbrella, so of course it does not rain. Thorax 2012;67(1):88-9. http://dx.doi.org/10.1136/thoraxjnl-2011-200758
21. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105(6):907-15. http://dx.doi.org/10.1016/j.rmed.2011.01.008
22. Alonso KLI, Ramos PDL, Glez-Moro JMR, CONSISTE Study Group. The use of the lower limit of normal as a criterion for COPD excludes patients with increased morbidity and high consumption of health care resources. Arch Bronconeumol 2012; 48(7):223-8. http://dx.doi.org/10.1016/j.arbr.2012.05.002
23. Mannino DM, Watt G, Hole D, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006;27(3):627-43. http://dx.doi.org/10.1183/09031936.06.00024605
24. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. Eur Respir J 2007;30(2):232-9. http://dx.doi.org/10.1183/09031936.00157906
25. Bakke PS, Rönmark E, Eagan T, et al. European Respiratory Society Task Force. Recommendations for epidemiological studies on COPD. Eur Respir J 2011;38(6): 1261-77. http://dx.doi.org/10.1183/09031936.00193809
26. Mannino DM. Defining chronic obstructive pulmonary disease. and the elephant in the room. Eur Respir J 2007;30(2):189-90. http://dx.doi.org/10.1183/09031936.00058707
27. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003;22(2):268-73. http://dx.doi.org/10.1183/09031936.03.00075102